These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 17997353

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Response of health care workers with isolated antibody to hepatitis B core antigen to hepatitis B vaccine.
    Chiarakul S, Eunumjitkul K, Vorapimol AR, Kaewkungwal J, Chimparlee N, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):831-8. PubMed ID: 22299465
    [Abstract] [Full Text] [Related]

  • 44. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC.
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [Abstract] [Full Text] [Related]

  • 47. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.
    Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C.
    J Infect Dis; 1999 Nov; 180(5):1444-51. PubMed ID: 10515802
    [Abstract] [Full Text] [Related]

  • 50. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
    Awerkiew S, Däumer M, Reiser M, Wend UC, Pfister H, Kaiser R, Willems WR, Gerlich WH.
    J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change.
    Ren F, Tsubota A, Hirokawa T, Kumada H, Yang Z, Tanaka H.
    Gene; 2006 Nov 15; 383():43-51. PubMed ID: 16963200
    [Abstract] [Full Text] [Related]

  • 53. Differential pattern of pre-S mutations/deletions and its association with hepatitis B virus genotypes in Eastern India.
    Biswas A, Panigrahi R, Banerjee A, Pal M, De BK, Chakrabarti S, Chakravarty R.
    Infect Genet Evol; 2012 Mar 15; 12(2):384-91. PubMed ID: 22266243
    [Abstract] [Full Text] [Related]

  • 54. [Characterization of hepatitis B virus strains from the Central African Republic: preliminary results].
    Bekondi C, Olinger CM, Boua N, Talarmin A, Venard V, Muller CP, Le Faou A.
    Pathol Biol (Paris); 2008 Jul 15; 56(5):310-3. PubMed ID: 18321662
    [Abstract] [Full Text] [Related]

  • 55. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
    Koyanagi T, Nakamuta M, Sakai H, Sugimoto R, Enjoji M, Koto K, Iwamoto H, Kumazawa T, Mukaide M, Nawata H.
    Med Sci Monit; 2000 Jul 15; 6(6):1165-9. PubMed ID: 11208474
    [Abstract] [Full Text] [Related]

  • 56. Mutation spectra of the surface-protein-coding region of the HBV genome in HBV-vaccinated and non-vaccinated individuals in Hungary.
    Szomor KN, Dencs A, Garai E, Rusvai E, Berencsi G, Takács M.
    Arch Virol; 2008 Jul 15; 153(10):1885-92. PubMed ID: 18813870
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
    Selabe SG, Song E, Burnett RJ, Mphahlele MJ.
    J Med Virol; 2009 Jun 15; 81(6):996-1001. PubMed ID: 19382250
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.
    J Gastroenterol Hepatol; 2008 Mar 15; 23(3):474-81. PubMed ID: 18318825
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.